Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer

Clinical trial NCT06766643 · RECRUITING

Trial details

NCT number: NCT06766643
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Liver Cancer

Start date: 2025-01-01
Primary completion: 2025-01-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.